NEW YORK – EverlyWell has added PerkinElmer to its network of laboratory providers, the companies announced today.
The first tests to be made available through the collaboration will be for Lyme disease and food sensitivity, leveraging Waltham, Massachusetts-based PerkinElmer's expertise. Both tests use dried blood spot testing and were developed by PerkinElmer Genomics. The partners also will work to expand Austin, Texas-based EverlyWell's test menu.
Additional terms of the deal were not disclosed.
"As we continue to expand our reach, we need best-in-class laboratory partners like PerkinElmer to ensure we can scale to meet demand while continuing to provide an unmatched customer experience," EverlyWell Founder and CEO Julia Cheek said in a statement.
EverlyWell is a home-based testing firm founded in 2015. In April it announced it raised $50 million to expand its digital platform and scale existing partnerships with companies such as CVS and Humana.